OpenURL Connection Search

Select item for more details and to access through your institution.

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy.
Published in:
Journal of Personalized Medicine, 2022, v. 12, n. 4, p. 618, doi. 10.3390/jpm12040618
By:
- Virgili Manrique, Anna C.;
- Salazar, Juliana;
- Arranz, María Jesús;
- Bagué, Silvia;
- Orellana, Ruth;
- López-Pousa, Antonio;
- Cerdà, Paula;
- Gracia, Isidre;
- Majercakova, Katarina;
- Peiró, Ana;
- Trullols, Laura;
- Fernández, Manuel;
- Valverde, Sandra;
- Quintana, María Jesús;
- Bell, Olga;
- Artigas-Baleri, Alícia;
- Sebio, Ana
Publication type:
Article
Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01).
Published in:
Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2155, doi. 10.1007/s12094-022-02868-x
By:
- Aparicio, Jorge;
- Virgili Manrique, Anna C.;
- Capdevila, Jaume;
- Muñoz Boza, Félix;
- Galván, Patricia;
- Richart, Paula;
- Oliveres, Helena;
- Páez, David;
- Hernando, Jorge;
- Serrano, Sara;
- Vera, Ruth;
- Hernandez-Yagüe, Xavier;
- Gallego, Rafael Álvarez;
- Riesco-Martinez, M. Carmen;
- García de Albeniz, Xavier;
- Maurel, Joan
Publication type:
Article
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Published in:
British Journal of Cancer, 2024, v. 130, n. 5, p. 777, doi. 10.1038/s41416-023-02563-w
By:
- Contreras-Toledo, Débora;
- Jiménez-Fonseca, Paula;
- López, Carlos López;
- Montes, Ana Fernández;
- López Muñoz, Ana María;
- Vázquez Rivera, Francisca;
- Alonso, Vicente;
- Alcaide, Julia;
- Salvà, Francesc;
- Covela Rúa, Marta;
- Guillot, Mónica;
- Martín Carnicero, Alfonso;
- Jimeno Mate, Raquel;
- Cameselle García, Soledad;
- Asensio Martínez, Elena;
- González Astorga, Beatriz;
- Fernandez-Diaz, Amaya B.;
- González Villaroel, Paula;
- Virgili Manrique, Anna C.;
- Melián Sosa, Marcos
Publication type:
Article

Found: 3

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy.

Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01).

Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?